ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för tadalafil. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

21 träffar

Bibliografisk träff 2013-02-01

Update on drug interactions with phosphodiesterase-5 inhibitors prescribed as first-line therapy for patients with erectile dysfunction or pulmonary hypertension.

Gur S, Kadowitz PJ, Gokce A, Sikka SC, Lokman U, Hellstrom WJ.

Curr Drug Metab · review; journal article · DOI 10.2174/1389200211314020014

Bibliografisk träff 2013-01-24

Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.

Giuliano F, Oelke M, Jungwirth A, Hatzimouratidis K, Watts S, Cox D, Viktrup L.

J Sex Med · multicenter study; randomized controlled trial; journal article · DOI 10.1111/jsm.12039

Bibliografisk träff 2013-01-24

Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of erectile dysfunction in men with type 2 diabetes mellitus.

Hamidi Madani A, Asadolahzade A, Mokhtari G, Shahrokhi Damavand R, Farzan A, Esmaeili S.

J Sex Med · randomized controlled trial; journal article · DOI 10.1111/jsm.12047

Bibliografisk träff 2013-01-01

Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

Dmochowski R, Roehrborn C, Klise S, Xu L, Kaminetsky J, Kraus S.

J Urol · multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.juro.2012.11.025

Bibliografisk träff 2012-12-20

Re: combination therapy of testosterone enanthate and tadalafil on PDE5 inhibitor non-responders with severe and intermediate testosterone deficiency.

Seftel AD.

J Urol · comment; journal article · DOI 10.1016/j.juro.2012.11.039

Bibliografisk träff 2012-12-12

Factors associated with adherence to phosphodiesterase type 5 inhibitors for the treatment of pulmonary arterial hypertension.

Waxman A, Chen SY, Boulanger L, Watson JA, Golden G.

J Med Econ · research support, non-u.s. gov't; journal article · DOI 10.3111/13696998.2012.756399

Bibliografisk träff 2012-12-05

Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells.

Weiss J, Theile D, Spalwisz A, Burhenne J, Riedel KD, Haefeli WE.

Biochem Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.bcp.2012.11.020

Bibliografisk träff 2012-11-28

Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.

Yamaguchi O.

Int J Urol · review; journal article · DOI 10.1111/iju.12008

Bibliografisk träff 2012-11-01

The selective phosphodiesterase-5 inhibitor tadalafil induces microvascular and metabolic effects in type 2 diabetic postmenopausal females.

Murdolo G, Sjöstrand M, Strindberg L, Lönnroth P, Jansson PA.

J Clin Endocrinol Metab · controlled clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1210/jc.2012-1830

Bibliografisk träff 2012-10-17

Common theme for drugs effective in overactive bladder treatment: inhibition of afferent signaling from the bladder.

Hood B, Andersson KE.

Int J Urol · review-article; review; journal article · DOI 10.1111/j.1442-2042.2012.03196.x

Bibliografisk träff 2012-10-08

Prophylactic effect of tadalafil on bladder function in a rat model of chronic bladder ischemia.

Nomiya M, Burmeister DM, Sawada N, Campeau L, Zarifpour M, Keys T, Peyton C, Yamaguchi O, Andersson KE.

J Urol · journal article · DOI 10.1016/j.juro.2012.07.141

Bibliografisk träff 2012-10-02

Identification of amino acid residues responsible for the selectivity of tadalafil binding to two closely related phosphodiesterases, PDE5 and PDE6.

Cahill KB, Quade JH, Carleton KL, Cote RH.

J Biol Chem · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1074/jbc.m112.389189

Bibliografisk träff 2012-09-19

Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: an experimental study in the rabbit.

Morelli A, Comeglio P, Filippi S, Sarchielli E, Vignozzi L, Maneschi E, Cellai I, Gacci M, Lenzi A, Vannelli GB, Maggi M.

Prostate · research support, non-u.s. gov't; journal article · DOI 10.1002/pros.22584

Bibliografisk träff 2012-09-13

Combination therapy of testosterone enanthate and tadalafil on PDE5 inhibitor non-reponders with severe and intermediate testosterone deficiency.

Kim JW, Oh MM, Park MG, Park JY, Bae JH, Kim JJ, Moon DG.

Int J Impot Res · journal article · DOI 10.1038/ijir.2012.32

Bibliografisk träff 2012-09-01

Optical coherence tomography in tadalafil-associated retinal toxicity.

Coscas F, Coscas G, Zucchiatti I, Bandello F, Soubrane G, Souïed E.

Eur J Ophthalmol · journal article; case reports · DOI 10.5301/ejo.5000127

Bibliografisk träff 2012-07-07

Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD.

García-Barroso C, Ricobaraza A, Pascual-Lucas M, Unceta N, Rico AJ, Goicolea MA, Sallés J, Lanciego JL, Oyarzabal J, Franco R, Cuadrado-Tejedor M, García-Osta A.

Neuropharmacology · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuropharm.2012.06.052

Bibliografisk träff 2012-06-27

Selective imaging of active pharmaceutical ingredients in powdered blends with common excipients utilizing two-photon excited ultraviolet-fluorescence and ultraviolet-second order nonlinear optical imaging of chiral crystals.

Toth SJ, Madden JT, Taylor LS, Marsac P, Simpson GJ.

Anal Chem · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1021/ac300917t

Bibliografisk träff 2012-03-24

Analysis of counterfeit Cialis® tablets using Raman microscopy and multivariate curve resolution.

Kwok K, Taylor LS.

J Pharm Biomed Anal · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jpba.2012.03.026

Bibliografisk träff 2011-09-22

Fingerprinting of sildenafil citrate and tadalafil tablets in pharmaceutical formulations via X-ray fluorescence (XRF) spectrometry.

Ortiz RS, Mariotti KC, Schwab NV, Sabin GP, Rocha WF, de Castro EV, Limberger RP, Mayorga P, Bueno MI, Romão W.

J Pharm Biomed Anal · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jpba.2011.09.005

Bibliografisk träff 2011-06-15

[Serous central chorioretinopathy and tadalafil: a case report].

Nadeau S, Nguyen F, Guigou S.

J Fr Ophtalmol · journal article; english abstract; case reports · DOI 10.1016/j.jfo.2011.02.016

Bibliografisk träff 2010-11-05

The phosphodiesterase type-5 inhibitor, tadalafil, improves depressive symptoms, ameliorates memory impairment, as well as suppresses apoptosis and enhances cell proliferation in the hippocampus of maternal-separated rat pups.

Baek SB, Bahn G, Moon SJ, Lee J, Kim KH, Ko IG, Kim SE, Sung YH, Kim BK, Kim TS, Kim CJ, Shin MS.

Neurosci Lett · journal article · DOI 10.1016/j.neulet.2010.10.074